1. Home
  2. MDGL vs PONY Comparison

MDGL vs PONY Comparison

Compare MDGL & PONY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • PONY
  • Stock Information
  • Founded
  • MDGL 2011
  • PONY 2016
  • Country
  • MDGL United States
  • PONY China
  • Employees
  • MDGL N/A
  • PONY N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • PONY
  • Sector
  • MDGL Health Care
  • PONY
  • Exchange
  • MDGL Nasdaq
  • PONY NYSE
  • Market Cap
  • MDGL 6.1B
  • PONY 4.4B
  • IPO Year
  • MDGL N/A
  • PONY 2024
  • Fundamental
  • Price
  • MDGL $304.86
  • PONY $12.96
  • Analyst Decision
  • MDGL Strong Buy
  • PONY Strong Buy
  • Analyst Count
  • MDGL 9
  • PONY 3
  • Target Price
  • MDGL $420.63
  • PONY $19.20
  • AVG Volume (30 Days)
  • MDGL 305.4K
  • PONY 13.8M
  • Earning Date
  • MDGL 08-06-2025
  • PONY 08-15-2025
  • Dividend Yield
  • MDGL N/A
  • PONY N/A
  • EPS Growth
  • MDGL N/A
  • PONY N/A
  • EPS
  • MDGL N/A
  • PONY N/A
  • Revenue
  • MDGL $317,383,000.00
  • PONY $76,483,000.00
  • Revenue This Year
  • MDGL $286.17
  • PONY $11.57
  • Revenue Next Year
  • MDGL $64.17
  • PONY $69.14
  • P/E Ratio
  • MDGL N/A
  • PONY N/A
  • Revenue Growth
  • MDGL N/A
  • PONY N/A
  • 52 Week Low
  • MDGL $200.63
  • PONY $4.11
  • 52 Week High
  • MDGL $377.46
  • PONY $23.88
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 61.70
  • PONY N/A
  • Support Level
  • MDGL $277.64
  • PONY N/A
  • Resistance Level
  • MDGL $314.22
  • PONY N/A
  • Average True Range (ATR)
  • MDGL 11.62
  • PONY 0.00
  • MACD
  • MDGL 3.11
  • PONY 0.00
  • Stochastic Oscillator
  • MDGL 82.64
  • PONY 0.00

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About PONY PONY AI INC SPON ADS EACH REP 1 COM CL A

Pony AI Inc is an artificial intelligence technology company that is principally engaged in the operation and development of autonomous vehicles. It operates fully driverless robotaxis through the PonyPilot mobile app in Beijing, Shanghai, Guangzhou, and Shenzhen. The company operates a fleet of robotaxis. The Group conducts its operations mainly in the People's Republic of China (PRC) and the United States of America (U.S.) through subsidiaries. Key revenue is generated from the People's Republic of China.

Share on Social Networks: